Back to Search
Start Over
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue.
- Source :
-
Future oncology (London, England) [Future Oncol] 2019 Feb; Vol. 15 (6), pp. 563-565. Date of Electronic Publication: 2019 Jan 16. - Publication Year :
- 2019
- Subjects :
- Anilides administration & dosage
Anilides adverse effects
Biomarkers, Tumor
Carcinoma, Hepatocellular metabolism
Humans
Liver Neoplasms metabolism
Molecular Targeted Therapy
Protein Kinase Inhibitors administration & dosage
Protein Kinase Inhibitors adverse effects
Pyridines administration & dosage
Pyridines adverse effects
Treatment Outcome
Anilides therapeutic use
Carcinoma, Hepatocellular complications
Carcinoma, Hepatocellular drug therapy
Hypothyroidism complications
Liver Neoplasms complications
Liver Neoplasms drug therapy
Protein Kinase Inhibitors therapeutic use
Pyridines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1744-8301
- Volume :
- 15
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Future oncology (London, England)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 30648889
- Full Text :
- https://doi.org/10.2217/fon-2018-0758